Piper publicly identifies Vials Rx as its compounding pharmacy partner in its Help Center a licensed U.S.-based 503A pharmacy that prepares prescriptions for individual patients
Research published in obesity journals confirms that appetite hormones like ghrelin spike within 2-4 weeks of stopping GLP-1 therapy, triggering intense food cravings and increased caloric intake
This prolonged digestive process can divert blood flow and energy, sometimes leading to that post-meal lethargy or a general feeling of being weighed down
Background and FDAs Announcement FDA's April 1, 2026, update to its compounding policy page follows more than 18 months of regulatory activity surrounding the compounding of GLP-1 medications, primarily semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound)
Glutathione regulates the actions of glutathione-peroxidases and glutathione-transferases, and theres research suggesting a direct relationship between glutathione concentration and mucosal damagewhen one goes up, the other goes down
